OREXIGEN THERAPEUTICS INC Common Stock

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch OREXQ and buy or sell other stocks, ETFs, and their options commission-free!

About OREXQ

Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. 

CEO
Michael A. Narachi, MBA
CEOMichael A. Narachi, MBA
Employees
Employees
Headquarters
La Jolla, California
HeadquartersLa Jolla, California
Founded
2002
Founded2002
Employees
Employees

OREXQ Key Statistics

Market cap
Market cap
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
18.01K
Average volume18.01K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.1598
52 Week high$0.1598
52 Week low
$0.001
52 Week low$0.001

Stock Snapshot

As of today, OREXIGEN THERAPEUTICS INC Common Stock(OREXQ) shares are valued at $0.01.

During the trading day, OREXIGEN THERAPEUTICS INC Common Stock(OREXQ) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 18.01K.

The stock's 52-week range extends from a low of $0.00 to a high of $0.16.

The stock's 52-week range extends from a low of $0.00 to a high of $0.16.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.